CN118216670A - Sports nutrition composition for promoting energy consumption and preparation method and application thereof - Google Patents
Sports nutrition composition for promoting energy consumption and preparation method and application thereof Download PDFInfo
- Publication number
- CN118216670A CN118216670A CN202311766405.1A CN202311766405A CN118216670A CN 118216670 A CN118216670 A CN 118216670A CN 202311766405 A CN202311766405 A CN 202311766405A CN 118216670 A CN118216670 A CN 118216670A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- energy consumption
- content
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 230000001737 promoting effect Effects 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 238000005265 energy consumption Methods 0.000 title abstract description 49
- 235000014268 sports nutrition Nutrition 0.000 title abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 43
- 235000003368 Ilex paraguariensis Nutrition 0.000 claims abstract description 21
- 244000188472 Ilex paraguariensis Species 0.000 claims abstract description 21
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 19
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 19
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 19
- 235000020744 piper nigrum extract Nutrition 0.000 claims abstract description 19
- 241001474374 Blennius Species 0.000 claims abstract description 18
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 17
- 241000512259 Ascophyllum nodosum Species 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims description 11
- 235000016709 nutrition Nutrition 0.000 claims description 11
- 238000005303 weighing Methods 0.000 claims description 11
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 claims description 10
- 239000005717 Laminarin Substances 0.000 claims description 10
- 229920001543 Laminarin Polymers 0.000 claims description 10
- 241000199919 Phaeophyceae Species 0.000 claims description 10
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 9
- 235000013824 polyphenols Nutrition 0.000 claims description 9
- SJWWTRQNNRNTPU-ABBNZJFMSA-N fucoxanthin Chemical compound C[C@@]1(O)C[C@@H](OC(=O)C)CC(C)(C)C1=C=C\C(C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C(=O)C[C@]1(C(C[C@H](O)C2)(C)C)[C@]2(C)O1 SJWWTRQNNRNTPU-ABBNZJFMSA-N 0.000 claims description 7
- AQLRNQCFQNNMJA-UHFFFAOYSA-N fucoxanthin Natural products CC(=O)OC1CC(C)(C)C(=C=CC(=CC=CC(=CC=CC=C(/C)C=CC=C(/C)C(=O)CC23OC2(C)CC(O)CC3(C)C)C)CO)C(C)(O)C1 AQLRNQCFQNNMJA-UHFFFAOYSA-N 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- 239000004376 Sucralose Substances 0.000 claims description 6
- 230000000386 athletic effect Effects 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 235000019408 sucralose Nutrition 0.000 claims description 6
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 6
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 5
- 239000004386 Erythritol Substances 0.000 claims description 5
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 5
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 5
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 5
- 229960004998 acesulfame potassium Drugs 0.000 claims description 5
- 239000000619 acesulfame-K Substances 0.000 claims description 5
- 229930013930 alkaloid Natural products 0.000 claims description 5
- 150000003797 alkaloid derivatives Chemical class 0.000 claims description 5
- 229960001948 caffeine Drugs 0.000 claims description 5
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 5
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 5
- 235000019414 erythritol Nutrition 0.000 claims description 5
- 229940009714 erythritol Drugs 0.000 claims description 5
- 239000001509 sodium citrate Substances 0.000 claims description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 5
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 4
- 229930003944 flavone Natural products 0.000 claims description 4
- 150000002212 flavone derivatives Chemical class 0.000 claims description 4
- 235000011949 flavones Nutrition 0.000 claims description 4
- 235000003599 food sweetener Nutrition 0.000 claims description 4
- 239000003765 sweetening agent Substances 0.000 claims description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 4
- 230000004580 weight loss Effects 0.000 claims description 4
- 229960004106 citric acid Drugs 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 229960002303 citric acid monohydrate Drugs 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 claims description 2
- 229960001518 levocarnitine Drugs 0.000 claims description 2
- 235000012054 meals Nutrition 0.000 claims 2
- 229930003935 flavonoid Natural products 0.000 claims 1
- 150000002215 flavonoids Chemical class 0.000 claims 1
- 235000017173 flavonoids Nutrition 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 230000000284 resting effect Effects 0.000 abstract description 17
- 235000013305 food Nutrition 0.000 abstract description 11
- 230000037080 exercise endurance Effects 0.000 abstract description 8
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 38
- 230000014509 gene expression Effects 0.000 description 26
- 230000004060 metabolic process Effects 0.000 description 25
- 239000000047 product Substances 0.000 description 19
- 241000699670 Mus sp. Species 0.000 description 15
- 235000019197 fats Nutrition 0.000 description 14
- 230000000694 effects Effects 0.000 description 12
- 230000009182 swimming Effects 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 230000029058 respiratory gaseous exchange Effects 0.000 description 6
- 238000000354 decomposition reaction Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical group OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 210000000577 adipose tissue Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000037149 energy metabolism Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000015494 Mitochondrial Uncoupling Proteins Human genes 0.000 description 3
- 108010050258 Mitochondrial Uncoupling Proteins Proteins 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 210000001789 adipocyte Anatomy 0.000 description 3
- 210000003486 adipose tissue brown Anatomy 0.000 description 3
- 210000000593 adipose tissue white Anatomy 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 102100029820 Mitochondrial brown fat uncoupling protein 1 Human genes 0.000 description 2
- 108050002686 Mitochondrial brown fat uncoupling protein 1 Proteins 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 235000006236 Paraguay tea Nutrition 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000003044 adaptive effect Effects 0.000 description 2
- 230000011759 adipose tissue development Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 2
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 description 2
- 229940075559 piperine Drugs 0.000 description 2
- 235000019100 piperine Nutrition 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000011885 synergistic combination Substances 0.000 description 2
- 235000021076 total caloric intake Nutrition 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000274177 Juniperus sabina Species 0.000 description 1
- 102000016267 Leptin Human genes 0.000 description 1
- 108010092277 Leptin Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000003939 Membrane transport proteins Human genes 0.000 description 1
- 108090000301 Membrane transport proteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000001596 intra-abdominal fat Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039781 leptin Drugs 0.000 description 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
- 229940040461 lipase Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000008437 mitochondrial biogenesis Effects 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 229940116369 pancreatic lipase Drugs 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 210000000636 white adipocyte Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention belongs to the technical field of sports nutrition food, and particularly relates to a sports nutrition composition for promoting energy consumption, a preparation method and application thereof. The composition comprises the following components in parts by weight: 0.2-1 part of lotus leaf powder, 3-10 parts of yerba mate extract, 1-10 parts of kelp extract, 1-6 parts of seaweed powder, 1-6 parts of black pepper extract and 5-20 parts of L-carnitine. The synergistic cooperation can improve the resting energy consumption of the machine body on one hand and the total energy consumption, namely the resting energy consumption and the movement energy consumption, on the other hand; on the other hand, the exercise endurance can be improved, and the purpose of losing weight is achieved from multiple aspects.
Description
Technical Field
The invention belongs to the technical field of sports nutrition food, and particularly relates to a sports nutrition food for controlling energy, namely promoting energy consumption and a preparation method thereof.
Background
Health problems caused by obesity have become a focus of social concern. Numerous studies have demonstrated that obesity can increase a person's risk of developing diabetes, heart disease, hypertension, sleep apnea, osteoarthritis, cancer, and other chronic diseases, and reduce the life expectancy of the patient.
The core of effective weight loss is a caloric gap, namely, daily caloric intake is smaller than consumption, and people can slowly lean down. In a specific practical process, we need to limit the total caloric intake by adjusting the dietary structure and then increase the caloric consumption by exercise, but in this process, what is considered is not only exercise-generated consumption, but also daily total caloric consumption, and the ways of daily body energy consumption are mainly three ways, namely resting energy consumption, active heat effect and food heat effect.
The resting energy consumption refers to the energy consumption of the organism after being fasted for more than 2 hours and lying for 30 minutes at a proper temperature, and is mainly used for maintaining the normal functions of cells and organs of the organism and the wakefulness state of the human body. And the resting energy consumption accounts for about 60-70% of the total daily energy consumption, so that the resting energy consumption of the organism is improved, and the weight-losing food has important significance.
However, the sports nutritional food sold in the market at present is basically only a few beverages or powders added with sugar, protein, mineral substances and vitamins, and the effects of the beverage or the powders are not ideal in improving the resting energy consumption and the exercise endurance, or the supplementing effect is too single and the pertinency is not strong.
Disclosure of Invention
To this end, the present invention provides an energy expenditure-promoting composition which, on the one hand, can increase resting energy expenditure; on the other hand, the administration before exercise can improve exercise endurance, prolong exercise time, further realize increase of exercise energy consumption and achieve the purpose of losing weight.
In order to realize the functions, the technical scheme adopted by the invention is as follows:
An athletic nutritional composition for promoting energy expenditure, comprising the following components in parts by weight: 0.2-1 part of lotus leaf powder, 3-10 parts of yerba mate extract, 1-10 parts of kelp extract, 1-6 parts of seaweed powder, 1-6 parts of black pepper extract and 5-20 parts of L-carnitine.
Preferably, the composition comprises the following components in parts by weight: 0.2-0.6 part of lotus leaf powder, 3-6 parts of yerba mate extract, 1-5 parts of kelp extract, 1-4 parts of seaweed powder, 1-3 parts of black pepper extract and 5-10 parts of L-carnitine.
Further preferred, the composition comprises the following components in weight: 0.5 part of lotus leaf powder, 4 parts of yerba mate extract, 3 parts of kelp extract, 3 parts of seaweed powder, 2 parts of black pepper extract and 10 parts of L-carnitine.
Preferably, the total flavone content in the lotus leaf powder is more than or equal to 0.2%.
Preferably, the total flavone content in the lotus leaf powder is more than or equal to 0.5 percent.
The content of caffeine in the Paraguay tea extract is more than or equal to 20%.
Preferably, the caffeine content in the yerba mate extract is more than or equal to 25%.
The content of fucoxanthin in the laminarin is more than or equal to 1 percent.
Preferably, the content of fucoxanthin in the laminarin is more than or equal to 2 percent.
The brown algae powder contains brown algae polyphenols more than 20%.
Preferably, the brown algae powder has a brown algae polyphenol content of >35%.
The alkaloid content in the black pepper extract is more than or equal to 60 percent.
Preferably, the alkaloid content in the black pepper extract is more than or equal to 95%.
A method for preparing the composition comprises weighing folium Nelumbinis powder, paraguay tea extract, laminarin, sargassum powder, fructus Piperis extract and L-carnitine, and mixing.
Use of a composition according to the above or a composition prepared by the above method of preparation for the preparation of a product for promoting energy expenditure and/or a product for weight loss.
An athletic nutritional product for enhancing energy expenditure comprising a composition as described above.
An athletic nutrition product for promoting energy consumption further comprises sweetener, acidity regulator and essence.
Preferably, the sweetener is at least one of erythritol, sucralose and acesulfame potassium.
The acidity regulator is at least one of citric acid, sodium citrate and sodium bicarbonate.
An athletic nutritional product for promoting energy expenditure, comprising the following components in parts by weight: 0.2-1 part of lotus leaf powder, 3-10 parts of yerba mate extract, 1-10 parts of kelp extract, 1-6 parts of seaweed powder, 1-6 parts of black pepper extract, 5-20 parts of L-carnitine, 70-80 parts of erythritol, 0.6-1 part of citric acid monohydrate, 0.4-1 part of sodium citrate, 0.05-0.1 part of sodium bicarbonate, 0.02-0.05 part of sucralose, 0.05-0.1 part of acesulfame potassium and 0.6-1 part of edible essence.
The preparation process includes the steps of weighing the materials in certain proportion and mixing for 15-30 min.
Compared with the prior art, the invention has the beneficial effects that:
(1) The invention provides a sports nutrition composition for promoting energy consumption, which comprises lotus leaf powder, yerba mate extract, laminarin, seaweed powder, black pepper extract and L-carnitine. Wherein the yerba mate extract can regulate gene expression of adipogenesis, thereby inhibiting adipogenesis, and the active ingredient polyphenols can inhibit pancreatic lipase and lipase, and slow gastric emptying to increase satiety, reduce food fat absorption and change cholesterol metabolism.
The kelp contains fucoxanthin, can be coupled with linoleic acid, so that the weight, intra-abdominal fat content, triglyceride (TG), blood sugar and leptin level of an obese rat are obviously reduced, and the fucoxanthin can inhibit the differentiation of adipocytes, induce brown of white adipocytes, regulate mitochondrial biogenesis and functional operation and regulate cholesterol metabolism.
The seaweed powder contains brown algae polyphenol which can inhibit the activities of glucosidase and amylase and reduce the digestion and absorption of human body on glucose, thereby reducing postprandial blood sugar rise; and brown algae polyphenols lead to AMPK-CPT-1 way, increase fatty acid beta oxidation of hepatocyte mitochondria, accelerate catabolism of fatty acid, brown algae polyphenols can also activate white adipose tissue, make it become "brown" or "beige" adipose tissue, in order to increase energy consumption, improve fat factor unbalance and inflammatory reaction.
Piperine in the piperine extract is a main functional substance, has an improving effect on 3T3-L1 insulin resistant adipocytes at the cellular level, can increase the sugar consumption capacity of the insulin resistant adipocytes, and has the effect of regulating lipid metabolism.
The L-carnitine can increase the oxidation rate of fat, promote the oxidation function of fat, reduce the consumption of glycogen, and delay fatigue and improve exercise capacity by reducing the establishment of lactic acid in muscle tissues.
The components are cooperatively matched, so that the resting energy consumption of the machine body can be improved, and the total energy consumption, namely the resting energy consumption and the movement energy consumption, can be improved; in yet another aspect, endurance to exercise may be improved. For the weight-losing population, the resting energy consumption of the organism is improved, which means that the purpose of losing weight can be achieved even without exercise. The improvement of total energy consumption and exercise endurance means that the time of organism feeling tired is prolonged, and the exercise time is prolonged, thereby realizing the combustion of more fat and achieving the purpose of losing weight.
(2) The sports nutrition product for promoting energy consumption provided by the invention is rich in taste, convenient to carry and easy to eat, and can increase the convenience and interestingness of eating while realizing sports weight loss; the invention has the advantages of no added sucrose, low energy and high dietary fiber content. Easy absorption, quick action, safety and no toxic or side effect, the energy of the product is less than or equal to 300kj/100g, the energy provided by the fat is less than or equal to 25 percent of the total energy of the product, and the product meets the requirements of GB 24154-2015 general rules for sports nutritional foods.
Detailed Description
For a better description of the objects, technical solutions and advantages of the present invention, the present invention will be further described with reference to the following specific examples. All other embodiments, which can be made by one of ordinary skill in the art without undue burden from the disclosure herein, are intended to be within the scope of the present disclosure. In the following examples, the experimental methods used are conventional methods unless otherwise specified, and the materials, reagents, etc. used are commercially available.
The specific sources of the raw materials used in the invention are as follows:
lotus leaf powder: purchased from Guangzhou Qingyun mountain pharmaceutical Co Ltd, the specification is that the total flavone content is not less than 0.5%;
Yerba mate extract: purchased from guangzhou Kang Lai food additives limited company, the caffeine content is more than or equal to 25%;
Kelp element: sea-tangle element (algae product) purchased from Hangzhou Ruilin chemical Co., ltd, the content of fucoxanthin is more than or equal to 2%;
seaweed powder: purchased from Tianjin coastal Jieji proprietary chemical industry Co., ltd, brown algae polyphenols content >35%;
black pepper extract: purchased from sabina (south Beijing) biotechnology limited company, the alkaloid content is more than or equal to 95%;
l-carnitine: purchased from kentai pharmaceutical company, limited, purity 99%;
erythritol: purchasing from Bobao biological stock Co.Ltd;
sucralose: purchased from saline Jiekang sucralose manufacturing Co., ltd;
Acesulfame potassium: purchased from the company of the Anhui Jinhe real Co., ltd;
Citric acid, sodium citrate, water: purchased from Weifang Yingxuan, inc.;
sodium bicarbonate: purchased from Tianjin taste and technology limited.
Examples 1 to 5
The components and parts ratios of the sports nutritional compositions for promoting energy expenditure provided in the examples of the present invention are shown in table 1 below. Wherein the total weight of the composition of each example is 100g, the preparation method comprises the following steps: (1) weighing ingredients: weighing various materials according to a proportion for standby. (2) And (3) pouring the weighed materials in the step (1) into a three-dimensional mixer after cleaning respectively, and mixing for 30 minutes.
Table 1 Each raw material component and parts in examples
Examples 6 to 11
The sports nutritional products provided in examples 6-11 of the present invention, which promote energy expenditure, have the components and parts shown in Table 2 below. Wherein the total weight of the composition of each example is 100g, the preparation method comprises the following steps: 1) Weighing and proportioning: weighing various materials according to a proportion for standby.
2) And (3) pouring the weighed materials in the step (1) into a three-dimensional mixer after cleaning respectively, and mixing for 30 minutes.
3) Pouring the materials mixed in the step 2) into an automatic packaging machine, and packaging into 10 g/serving according to the requirement.
TABLE 2 raw material components and parts in examples 6-11
The total weight of the composition of the example was 100g, and the preparation method thereof comprises the following steps:
(1) Weighing and proportioning: weighing various materials according to a proportion for standby. (2) And (3) pouring the weighed materials in the step (1) into a three-dimensional mixer after cleaning respectively, and mixing for 30 minutes.
Table 3 comparative examples of the raw material components and parts
Nutrient detection
The sports nutritional products obtained in example 11, which promote energy expenditure, were analyzed and the results are shown in table 4.
Table 4 table of nutrient composition
The requirements of Table 1 in technical index 4.3 of the general rule of sports nutrition food of GB 24154-2015 are that the energy of the solid product for controlling energy class-promoting energy consumption is less than or equal to 300KJ/100g, the energy provided by fat is less than or equal to 25% of the total energy of the product, as can be seen from Table 4, the energy of the product is 194KJ/100g, the energy of the product meets the requirements of the standard energy value of less than or equal to 300KJ/100g, the energy provided by fat is 0KJ, the energy provided by fat meets the requirements of the standard energy provided by fat is less than or equal to 25% of the total energy of the product, and the product meets the requirements of the general rule of sports nutrition food of GB 24154-2015, and the product is a sports nutrition-controlling energy (promoting energy consumption) class product.
Experimental example 2 Experimental example for improving resting energy consumption
1.1 Subjects:
120 male mice with the age of 6 weeks are bred in separate cages after being marked with earmarks, and the breeding environment temperature is 22+/-2 ℃ and the humidity is 50+/-10%. All mice were randomly divided into 12 groups after 1 week of normal feed adaptive feeding: vitamin C group (blank group) and example group (example 1 group, example 2 group, example 3 group, example 4 group and example 5 group), comparative example group (comparative example 1 group, comparative example 2 group, comparative example 3 group, comparative example 4 group, comparative example 5 group and comparative example 6 group).
1.2 Experimental procedure:
1.2.1 mouse metabolism assay:
After the experiment starts, placing the mice into a metabolism cage for environmental adaptation for 24 hours, and collecting VCO 2 and VO 2 data for 24 hours from 8:30 in the morning of the next day to 8:30 in the morning of the third day, which is the pre-measurement data of the mice; on the third day of the experiment, the blank group was filled with 200 μl of vitamin C solution (10 mgVC powder dissolved in 10ml of water), the example group and the comparative group were respectively filled with 200 μl of the corresponding composition solution (1 g powder dissolved in 10ml of water), and the VCO 2 and VO 2 data were recorded for a total of 24 hours from 8:30 on the third morning to 8:30 on the fourth morning.
1.2.2 UCP-1, HSL, beta-AR 3 expression level measurement
After the metabolic test of the mice is finished, the mice are continuously fed for 4 days by using a conventional mouse cage, and the mice are sacrificed after neck breakage. Serum, back brown fat and white fat were removed, and UCP-1, HSL and beta-AR 3 expression levels were detected by the Real time-PCR method.
1.3 Data processing
Respiration Entropy (RER): respiratory entropy refers to the ratio of the volume of carbon dioxide released by an organism to the volume of oxygen absorbed at the same time. The instrument measures the volume of oxygen and carbon dioxide change (in ml/kg/hr) through the gas sensor and derives the value of respiration entropy using the formula rer=vco 2/VO2.
Energy consumption (HEAT): energy expenditure refers to the process of consuming energy in the body, i.e., the process of energy metabolism, when the mouse is active. The usual unit is the energy metabolism rate, i.e. the energy metabolism per unit time. Energy expenditure (HEAT) is here the total expenditure, which is the sum of basal metabolism and active metabolism. HEAT is calculated by indirect measurement, and the formula is heat= (3.815+1.232 rer) VO 2. The energy expenditure value of each mouse was calibrated uniformly with the weight, i.e. energy expenditure/body weight, in kcal/kg/hr.
Basal metabolism refers to the energy metabolism of a mouse in a basal state, i.e., in an awake state, without being affected by factors such as muscle activity, ambient temperature, food, etc. The basal metabolism here was converted by indirect means, i.e. the energy expenditure (HEAT) of the mice in the resting state over 3 statistical periods (statistical data every 10 min). The energy expenditure of 30min in each mouse in the resting state was converted to basal metabolism and then uniformly calibrated with body weight, i.e., basal expenditure/body weight in kcal/kg/hr.
1.4 Experimental results
1.4.1 Metabolism related value
The results of the respiration entropy, basal metabolism, unit basal metabolism, energy consumption and unit energy consumption of the blank group, examples 1 to 5, and comparative examples 1 to 6 are shown in Table 5.
TABLE 5
Wherein the respiration entropy of examples 1-5 is compared with that of the blank group, and P is less than 0.01, and P is less than 0.05; the basal metabolic values of examples 1-5 were compared to the placebo group, # indicated P < 0.01, # indicated P < 0.05; comparison of the unit basal metabolism of examples 1-5 with the model group, αα represents P < 0.01, and α represents P < 0.05; the energy consumption of examples 1-5 was compared to the placebo group, ββ representing P < 0.01, and β representing P < 0.05; the specific energy consumption of examples 1-5 was compared to the blank, with gamma representing P < 0.01 and gamma representing P < 0.05.
The respiratory entropy of comparative examples 1-6 was compared with that of example 5, AA representing P < 0.01, A representing P < 0.05; the basal metabolism of comparative examples 1 to 6 was compared with that of example 5, BB represents P < 0.01, and B represents P < 0.05; the unit basal metabolism of comparative examples 1 to 6 was compared with that of example 5, CC representing P < 0.01, C representing P < 0.05; the energy consumption of comparative examples 1 to 6 was compared with that of example 5, DD represents P < 0.01, D represents P < 0.05; the unit energy consumption of comparative examples 1 to 6 was compared with that of example 5, EE represents P < 0.01, and P < 0.05.
As can be seen from Table 4, the respiration entropy, basal metabolism, unit basal metabolism, energy consumption, and unit energy consumption of examples 1-5 were all significantly higher than those of the control group (p < 0.01), wherein the significant differences in basal metabolism and unit basal metabolism indicate that the composition of the present invention can increase basal metabolism consumption, i.e., resting energy consumption; the significant differences in energy consumption and unit energy consumption also indicate that the compositions provided by the present invention can promote resting energy consumption and exercise energy consumption. Comparative examples 1-6 compared with example 5, the composition prepared in example 5 has significantly higher respiration entropy, basal metabolism, unit basal metabolism, energy consumption and unit energy consumption than the comparative example (p < 0.01), thus demonstrating that the synergistic combination of lotus leaf powder, yerba mate extract, laminarin, seaweed powder, black pepper extract and L-carnitine realizes the effect of promoting energy consumption of the composition.
1.4.2 UCP1mRNA expression level
The UCP1mRNA expression levels of the blank, examples 1 to 5, and comparative examples 1 to 6 are shown in Table 6.
Wherein the UCP1mRNA expression level of examples 1-5 is compared with that of the blank control group, wherein P is less than 0.01, and P is less than 0.05; UCP1mRNA expression levels of comparative examples 1 to 6 were compared with example 5, and # indicates P < 0.01 and # indicates P < 0.05.
As shown in Table 5, the UCP1mRNA expression levels were significantly different (p < 0.01) in examples 1 to 5 compared to the blank group, and were significantly different (p < 0.01) in comparative examples 1 to 6 compared to example 5.
1.4.3 HSLmRNA expression level
The expression levels of HSLmRNA in the blank, examples 1 to 5, and comparative examples 1 to 6 are shown in Table 7.
TABLE 7
Wherein HSLmRNA of examples 1-5 expressed in amounts comparable to the blank, P <0.01 and P < 0.05; the HSLmRNA expression levels of comparative examples 1 to 6 were compared with example 5, # represents P <0.01, and # represents P < 0.05.
As shown in Table 6, the HSL mRNA expression levels of examples 1 to 5 were extremely significantly different (p < 0.01) from those of the blank control group, and the HSLmRNA expression levels of comparative examples 1 to 6 were extremely significantly different (p < 0.01) from those of comparative example 5.
4.1.4 Beta-AR 3mRNA expression level
The expression levels of the β -AR3mRNA of the blank, examples 1 to 5 and comparative examples 1 to 6 are shown in Table 8.
TABLE 8
Wherein the β -AR3mRNA expression levels of examples 1-5 were compared to the blank, representing P < 0.01, representing P < 0.05; the expression level of the beta-AR 3mRNA of comparative examples 1 to 6 was compared with that of example 5, and # represents P < 0.01 and # represents P < 0.05.
As shown in Table 7, the expression level of β -AR3mRNA was significantly different (p < 0.01) in examples 1 to 5 compared to the blank group, and the expression level of β -AR3mRNA was significantly different (p < 0.01) in example 5 compared to comparative examples 1 to 6.
UCP1 (mitochondrial brown fat uncoupling protein 1) is a mitochondrial inner membrane transport protein responsible for heat production, and the expression of UCP1mRNA can reflect the condition of white fat browning and brown fat heat production, further reflect the condition of organism metabolic rate, and indicate that the higher the brown fat heat production is, the more energy consumption is indicated by the higher the expression quantity of UCP1 mRNA. The release of epinephrine can activate the fat beta-3 receptor (beta-AR 3), inhibit the activity of phosphodiesterase, promote the hydrolysis of triglyceride into fatty acid, accelerate the decomposition of fat, and show that the higher the expression level of beta-AR 3mRNA, the higher the decomposition speed of fat and the higher the metabolism rate. Hormone sensitive triglyceride lipase (HSL) is a key enzyme and a speed-limiting enzyme for initial start of triglyceride decomposition in adipose tissues, is responsible for decomposing triglyceride in adipose tissues to release free fatty acid, is the most key factor for regulating the decomposition of adipose tissues, and is also one of key enzymes for influencing the fat deposition of animals. The higher the HSLmRNA expression quantity is, the higher the fat decomposition speed is, and the metabolism rate is improved. Results of UCP1mRNA expression level, HSLmRNA expression level and beta-AR 3mRNA expression level show that the composition prepared from lotus leaf powder, yerba mate extract, laminarin, seaweed powder, black pepper extract and L-carnitine can accelerate lipolysis, increase organism resting energy consumption and improve metabolism rate.
Experimental example 3 mouse exercise endurance test
The testing process comprises the following steps: 120 healthy male mice, weighing 20-23g, were randomly divided into 13 groups by body mass after 7d of adaptive feeding, and divided into a blank group, an example group (example 1 group, example 2 group, example 3 group, example 4 group and example 5 group), and a comparative example group (comparative example 1 group, comparative example 2 group, comparative example 3 group, comparative example 4 group, comparative example 5 group and comparative example 6 group). The mice were swimming trained using a standard mouse swimming pool at about 25 ℃ for 30d swimming exercises and the exhausted swimming was performed on day 30. The blank group was fed with normal feed and drinking water, and the remaining groups were given 10mL/kg BW of the compositions of examples 1-5 and comparative examples 1-6, respectively, in addition to the normal feed and drinking water. The mice were subjected to a running-out swimming test on day 30, so that the mice were loaded with 8% copper wires, and each group of mice reached a running-out state, and corresponding running-out time was recorded strictly according to the running-out judgment standard (when the heads of the mice were immersed in the water for 10s and were unable to float out). Test results: as shown in table 9.
TABLE 9 results of mice exercise endurance experiments
Wherein the depletion swimming times min of examples 1-5 are compared with the blank control group, wherein P < 0.01 and P < 0.05; the depletion swimming times min of comparative examples 1-6 are compared with example 5, # indicates P < 0.01, # indicates P < 0.05.
As shown in the table above, examples 1-5 and the control group of the blank group are compared, and the exhaustion time is extremely higher than that of the blank group (p is less than 0.01), so that the composition of the invention has good effect of improving exercise endurance. Compared with comparative examples 1-6, the compositions prepared in examples 1-5 have a swimming time of more than 60min, and the compositions prepared in comparative examples 1-6 have a swimming time of less than 60min due to the lack of one of the raw material components, thereby demonstrating that the exercise endurance effect achieved by the synergistic combination of the lotus leaf powder, yerba mate extract, laminarin, seaweed powder, black pepper extract and L-carnitine is good.
The invention has been further described above in connection with specific embodiments, which are exemplary only and do not limit the scope of the invention in any way. It will be understood by those skilled in the art that various changes and substitutions of details and forms of the technical solution of the present invention may be made without departing from the spirit and scope of the present invention, but these changes and substitutions fall within the scope of the present invention.
Claims (10)
1. An athletic nutritional composition for promoting energy expenditure, comprising the following components in parts by weight: 0.2-1 part of lotus leaf powder, 3-10 parts of yerba mate extract, 1-10 parts of kelp extract, 1-6 parts of seaweed powder, 1-6 parts of black pepper extract and 5-20 parts of L-carnitine.
2. The composition of claim 1, comprising the following components by weight: 0.2-0.6 part of lotus leaf powder, 3-6 parts of yerba mate extract, 1-5 parts of kelp extract, 1-4 parts of seaweed powder, 1-3 parts of black pepper extract and 5-10 parts of L-carnitine.
3. The composition of claim 2, comprising the following components by weight: 0.5 part of lotus leaf powder, 4 parts of yerba mate extract, 3 parts of kelp extract, 3 parts of seaweed powder, 2 parts of black pepper extract and 10 parts of L-carnitine.
4. A composition according to claim 1, wherein the total flavonoids content of the lotus leaf powder is not less than 0.2%; preferably, the total flavone content in the lotus leaf powder is more than or equal to 0.5%;
The caffeine content in the yerba mate extract is more than or equal to 20%; preferably, the caffeine content in the yerba mate extract is more than or equal to 25%;
the content of fucoxanthin in the laminarin is more than or equal to 1 percent; preferably, the content of fucoxanthin in the laminarin is more than or equal to 2%;
The brown algae polyphenol content in the seaweed meal is more than 20%; preferably, the brown algae polyphenol content in the seaweed meal is more than 35%;
The alkaloid content in the black pepper extract is more than or equal to 60%; preferably, the alkaloid content in the black pepper extract is more than or equal to 95%.
5. A method for preparing the composition of any one of claims 1 to 4, comprising the step of weighing and mixing lotus leaf powder, yerba mate extract, laminarin, seaweed powder, black pepper extract and l-carnitine uniformly.
6. Use of a composition according to any one of claims 1-4 or a composition obtainable by a process according to claim 5 for the preparation of a product for promoting energy expenditure and/or a product for weight loss.
7. An athletic nutritional product for enhancing energy expenditure, comprising a composition according to any one of claims 1-4.
8. The product of claim 7, further comprising a sweetener, an acidity regulator, and a flavor; preferably, the sweetener is at least one of erythritol, sucralose and acesulfame potassium; the acidity regulator is at least one of citric acid, sodium citrate and sodium bicarbonate.
9. The product according to claim 8, characterized by comprising the following components in parts by weight: 0.2-1 part of lotus leaf powder, 3-10 parts of yerba mate extract, 1-10 parts of kelp extract, 1-6 parts of seaweed powder, 1-6 parts of black pepper extract, 5-20 parts of L-carnitine, 70-80 parts of erythritol, 0.6-1 part of citric acid monohydrate, 0.4-1 part of sodium citrate, 0.05-0.1 part of sodium bicarbonate, 0.02-0.05 part of sucralose, 0.05-0.1 part of acesulfame potassium and 0.6-1 part of edible essence.
10. A method of preparing a product according to any one of claims 7 to 9, comprising the step of weighing each of the materials in proportions and mixing for 15 to 30 minutes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311766405.1A CN118216670A (en) | 2023-12-21 | 2023-12-21 | Sports nutrition composition for promoting energy consumption and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311766405.1A CN118216670A (en) | 2023-12-21 | 2023-12-21 | Sports nutrition composition for promoting energy consumption and preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118216670A true CN118216670A (en) | 2024-06-21 |
Family
ID=91503744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311766405.1A Pending CN118216670A (en) | 2023-12-21 | 2023-12-21 | Sports nutrition composition for promoting energy consumption and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN118216670A (en) |
-
2023
- 2023-12-21 CN CN202311766405.1A patent/CN118216670A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105050594B (en) | For generating the composition and method that increase with lasting ketosis | |
| CN101953442B (en) | Health care product with function of reducing blood sugar | |
| CN104982928B (en) | A kind of japanese yew fruit health care ferment and preparation method thereof | |
| CN102366093A (en) | Composite slimming health food | |
| KR102107387B1 (en) | Beverage composition for treating hangover comprising black ginseng extact | |
| CN102355898A (en) | Agent for promoting energy consumption | |
| CN105876585A (en) | Protein solid beverage and preparation method and application thereof | |
| CN108094646A (en) | A kind of function candy relieved stress and preparation method thereof | |
| CN101208080A (en) | Medicament for the treatment of impaired glucose metabolism | |
| CN105031042A (en) | Medicinal composition having weight-loss function and application of medicinal composition | |
| KR100747481B1 (en) | Cracker and method for producing thereof | |
| CN102273581A (en) | Compound sweetener with high sweetness | |
| WO2015127314A1 (en) | Activated soy pod fiber | |
| CN102366094A (en) | Fat-reducing and hypolipemic health food | |
| CN116210831A (en) | Sleep-aiding dragon fruit fermented beverage and preparation method thereof | |
| CN103689089A (en) | Pollen and almond powder beverage and preparation method thereof | |
| CN118216670A (en) | Sports nutrition composition for promoting energy consumption and preparation method and application thereof | |
| CN114601905B (en) | Blood-nourishing sleep-improving oral liquid and preparation process thereof | |
| JP2004149471A (en) | Hypoglycemic agent | |
| CN115886112A (en) | Composition for improving metabolism and tablet candy | |
| DK2882280T3 (en) | MUTTERED TOMATOES AND ITS USE FOR PREVENTION AGAINST WEIGHT INCREASE AND / OR TREATMENT OF FEDERAL RELATED DISEASES | |
| CN103355665B (en) | A kind of composition for auxiliary hyperglycemic | |
| CN102423005A (en) | Production method of egg with low cholesterol, rich selenium, and rich chromium | |
| CN105381313A (en) | Vitamin D composition and application thereof | |
| CN115413787B (en) | Composition and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |